We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Approves First Generic of Roche’s Cancer Drug Xeloda
FDA Approves First Generic of Roche’s Cancer Drug Xeloda
September 24, 2013
The FDA Sept. 16 approved Teva’s generic version of Roche’s cancer drug Xeloda. It is the first generic copy of Xeloda (capecitabine), an oral chemotherapy pill, to gain the FDA’s approval.